Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2000
04/26/2000CN1251527A Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations
04/26/2000CN1251526A New therapeutic combinations of mirtazapine and antipsychotic agents, for treatment of prophylaxis of psychotic disorders
04/26/2000CN1251525A Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating AIDS
04/26/2000CN1251524A Pharmaceutical composition for oral administration of N-piperidino-3-phrazolecarboxamide derivative, its salts and their solvates
04/26/2000CN1251523A Sulphonamide derivatives
04/26/2000CN1251522A Antirheumatic agents
04/26/2000CN1251521A Compound and method for therapeutic intervention in preventing diabetic complications
04/26/2000CN1251520A Use of sodium channel blocker in manfacture of medicament for preventing optic nerve degeneration associated with glaucoma
04/26/2000CN1251370A Method for preparing anti-cancer medicine total saponin of Glycyrrhisa uralensis
04/26/2000CN1251365A Method for purifying and crystallizing vitamin B2
04/26/2000CN1251364A 7-chloro-4-oxo-quinoline and its preparation method and novel use as medicine
04/26/2000CN1251312A Stable complex of insoluble chemical compound
04/26/2000CN1251310A Chinese medicine for treating hyperosteogeny, arthritis and herniation of cervical disc and prolapse of lumbar intervertebral disc and administration device thereof
04/26/2000CN1251297A Benzimidazole enteric coating preparation and preparing method thereof
04/26/2000CN1251296A Use of anticancer material and production method of said anti-cancer material
04/26/2000CN1051767C Benzoxazinones as inhibitors of HIV reverse transcriptase
04/26/2000CN1051766C Angiotension II antagonist imidazole derivatives, their preparation and therapeutic use
04/26/2000CN1051762C Vitamin D3 analogs, preparation method and use, and medicinal composition containing same
04/26/2000CN1051758C Anti-androgenic cyclo and bicycle alkenes
04/26/2000CN1051706C Amino-quinazoline hydride compound and novel use of its derivative to abstain from and reducing medicine dependence
04/26/2000CN1051705C Composition comprising tramadol material and any of codeine, oxycodone or hydrocodone and their use thereof
04/26/2000CN1051704C Composition containing retionic acids and tocopherol
04/26/2000CN1051703C Process for preparing medicinal composition containing oxaspiro [2,5] octane derivatives and its salt thereof
04/26/2000CN1051702C Preparation process for fungusicide composition
04/25/2000US6054614 Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds
04/25/2000US6054599 Phytosphingosine-based ceramide I analogs
04/25/2000US6054591 Lymph-absorbable aryl substituted imidazole derivatives
04/25/2000US6054590 Imidazolone anorectic agents: II. phenyl derivatives
04/25/2000US6054588 Heterocyclic vinyl ethers
04/25/2000US6054578 Method for adsorbing cholesterol oxide, and process for producing foods containing cholesterol or cholesterol oxide
04/25/2000US6054560 Mitogen activated protein kinase, FRK
04/25/2000US6054558 Amino acid sequence of isolated polypeptide from gene upregulated in endothelial cells in response to shear stress; for treatment and diagnosis of atherosclerosis, hypertension, ischemia/reperfusion, restenosis, and arterial inflammation
04/25/2000US6054491 Administering one type of xanthophylles in the feed to mammals
04/25/2000US6054490 Use of sesquiterpenes for inhibiting oxidative enzymes
04/25/2000US6054489 Method for the enhancement of lymphocyte activity against tumors
04/25/2000US6054488 Or its acid addition salt containing ethanol and surfactantother than acetylated monoglycerides; no change crystalmorphology on storage; redispersible
04/25/2000US6054487 Methods and compositions for modulating responsiveness to corticosteroids
04/25/2000US6054486 Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease
04/25/2000US6054485 Eye treatments using synthetic thyroid hormone compositions
04/25/2000US6054484 Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same
04/25/2000US6054482 Hydrolysis of gabapentin or the lactam to form acid addition salt, conversion to pure compound by ion exchanging; antiepileptic agents
04/25/2000US6054481 Containing palmitic, oleic and linoleic acids
04/25/2000US6054480 Acids or metal salts containing twelve to fifteen carbon atoms
04/25/2000US6054479 Preservative compositions and methods for using the same
04/25/2000US6054478 Antifungal sordaridin derivatives
04/25/2000US6054477 Anti-first-pass effect compounds
04/25/2000US6054475 Substituted dihydrobenzofuran-based phosphodiesterase 4 inhibitors useful for treating airway disorders
04/25/2000US6054474 Activating opioid receptors
04/25/2000US6054472 Inhibitors of IMPDH enzyme
04/25/2000US6054471 Use of fluorinated triazoles in treating neuropathic pain
04/25/2000US6054470 Src family SH2 domain inhibitors
04/25/2000US6054468 Metastasis
04/25/2000US6054467 Induction of apoptosis in cancer cells following treatment with inhibitors of dna repair in combination with p53.
04/25/2000US6054465 Used to stimulate hematopoiesis and for the treatment of bacterial infectious diseases.
04/25/2000US6054464 Azabicyclic esters of carbamic acids useful in therapy
04/25/2000US6054463 Methods for treating dermatitis using descarboethoxyloratadine
04/25/2000US6054462 Intranasal antimigraine compositions
04/25/2000US6054461 Treatment of neuropathic pain
04/25/2000US6054460 Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]pyrimidines, and process for preparing
04/25/2000US6054457 Benzamide derivatives and their use as vasopressin antagonists
04/25/2000US6054455 Method for treating or preventing chronic nonbacterial prostatitis and prostatodynia
04/25/2000US6054453 Hypolipidemic, antihyperglycemic uses.
04/25/2000US6054452 N-oxides of heterocyclic esters, amides, thioesters, and ketones
04/25/2000US6054451 The effectiveness of (r) or (s) 5-(2-azetidinylmethoxy)-2-chloropyridine, is significantly potentiated by administering an analgesic-potentiating amount for said analgesic of at least one nontoxic nmda receptor
04/25/2000US6054450 Solution of zinc pyrithione in n-acylethylenediaminetriacetate.
04/25/2000US6054449 Photodynamic therapy
04/25/2000US6054448 2-amino-2-(3-substituted cyclobutyl) acetic acid derivatives
04/25/2000US6054447 Progesterone for treating or reducing ischemia
04/25/2000US6054446 17-substituted-17-desoxy-1,3,5-estratrienes.
04/25/2000US6054445 Kappa opioid agonist activity; analgesics and anti-pruritic agents
04/25/2000US6054444 Inhibit n-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme activity
04/25/2000US6054443 Exocellular polysaccharide produced by Streptococcus thermophilus
04/25/2000US6054442 Methods and compositions for modulation and inhibition of telomerase in vitro
04/25/2000US6054441 Antiinflammatory agents; treatment of bacterial, viral or fungal infections; autoimmune diseases
04/25/2000US6054439 Antisense olignucleotides having tumorigenicity-inhibiting activity
04/25/2000US6054437 Method for inducing death of neoplastic cells using piperazine derivatives
04/25/2000US6054434 8a-azalides as veterinary antimicrobal agents
04/25/2000US6054433 Administering to the subject a composition comprising at least one inhibitor of an enzyme having beta-glucosidase activity in an amount effective in stimulating the proliferation of keratinizing epithelium of said subject.
04/25/2000US6054432 Means for treating prostate hypertrophy and prostate cancer
04/25/2000US6054431 Anti-gram-positive bacterial methods and materials
04/25/2000US6054430 Substantially free of species having a molecular weight of over 40 kilodaltons; trifluoroacetyl copolymer-1 treated with hbr.
04/25/2000US6054428 Allow the toxic effects of cytotoxic drugs, e.g., cyclosporin, when used at high dosages or over prolonged times to be alleviated or even suppressed.
04/25/2000US6054320 Includes a regent which binds to effector of arachidonic acid release in biopsy sample cells and another reagent for detectably labelling binding agent; for early, accurate diagnosis
04/25/2000US6054273 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents
04/25/2000US6054145 Making dosage units using low shear granulation
04/25/2000US6054144 Spray drying oryzanol suspended in an aqueous surfactant mixture
04/25/2000US6054143 Xylitol delivery
04/25/2000US6054140 Long acting injectable parasiticidal composition and the process for its preparation
04/25/2000US6054137 Promoting epidermal renewal with phloroglucinol
04/25/2000US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection
04/25/2000CA2196538C Process for making antimicrobial compounds
04/25/2000CA2177990C Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation
04/25/2000CA2143849C Substituted thiazolidinedione derivatives
04/25/2000CA2110386C Method for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
04/25/2000CA2105575C Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
04/25/2000CA2070095C Microspheres containing biologically-active components, processes for the preparation and uses
04/25/2000CA2045453C Condensed heterocyclic compound and psychopharmaceutical composition containing same
04/25/2000CA2015671C Phosphonomethoxytetrahydrofuranyl-purine/pyrimidine derivatives
04/25/2000CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids
04/23/2000CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction